These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9563667)

  • 1. p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival.
    Rowley H; Roland NJ; Helliwell TR; Caslin A; Kinsella AR; Jones AS
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):57-62. PubMed ID: 9563667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions.
    Volavsek M; Bracko M; Gale N
    J Laryngol Otol; 2003 Apr; 117(4):286-93. PubMed ID: 12816218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protein P53 in laryngeal cancer--no evidence of prognostic value].
    Woińska-Rojecka T; Chodynicki S; Chyczewski L; Pogumirski J
    Otolaryngol Pol; 2001; 55(1):53-6. PubMed ID: 11355478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 overexpression in head and neck carcinoma and radiotherapy results.
    Awwad S; Jaros E; Somes J; Lunec J
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):323-32. PubMed ID: 8567333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.
    Spafford MF; Koeppe J; Pan Z; Archer PG; Meyers AD; Franklin WA
    Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):627-32. PubMed ID: 8639294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma.
    Klatka J
    Eur Arch Otorhinolaryngol; 2001 Dec; 258(10):537-41. PubMed ID: 11829192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
    Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
    Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
    Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
    J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors.
    Nadal A; Campo E; Pinto J; Mallofré C; Palacín A; Arias C; Traserra J; Cardesa A
    J Pathol; 1995 Feb; 175(2):181-8. PubMed ID: 7738713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
    Franklin S; Pho T; Abreo FW; Nassar R; De Benedetti A; Stucker FJ; Nathan CO
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):177-82. PubMed ID: 10037284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of EGFR and p53 expression, and angiogenesis in laryngeal squamous cell carcinoma].
    Watanabe H; Suzuki T; Ito Y; Mizuta K; Sawai S; Miyata H
    Nihon Jibiinkoka Gakkai Kaiho; 1999 Feb; 102(2):243-53. PubMed ID: 10191626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCCIP as a prognostic marker for radiotherapy of laryngeal cancer.
    Rewari A; Lu H; Parikh R; Yang Q; Shen Z; Haffty BG
    Radiother Oncol; 2009 Feb; 90(2):183-8. PubMed ID: 19046788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization.
    Lukits J; Timár J; Juhász A; Döme B; Paku S; Répássy G
    Otolaryngol Head Neck Surg; 2001 Jul; 125(1):18-22. PubMed ID: 11458208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
    Esser D; Anke S; Roessner A; Freigang B
    Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck.
    Lavieille JP; Brambilla E; Riva-Lavieille C; Reyt E; Charachon R; Brambilla C
    Acta Otolaryngol; 1995 Mar; 115(2):334-9. PubMed ID: 7610836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of histone demethylase PHF8 associates with adverse prognosis in patients of laryngeal and hypopharyngeal squamous cell carcinoma.
    Zhu G; Liu L; She L; Tan H; Wei M; Chen C; Su Z; Huang D; Tian Y; Qiu Y; Liu Y; Zhang X
    Epigenomics; 2015; 7(2):143-53. PubMed ID: 25496457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus and p53 oncoprotein in verrucous carcinoma of the larynx.
    López-Amado M; García-Caballero T; Lozano-Ramírez A; Labella-Caballero T
    J Laryngol Otol; 1996 Aug; 110(8):742-7. PubMed ID: 8869607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.
    Salerno G; Di Vizio D; Staibano S; Mottola G; Quaremba G; Mascolo M; Galli V; De Rosa G; Insabato L
    BMC Cancer; 2006 Jun; 6():146. PubMed ID: 16740156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.